Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a new platform/UI version. This update does not modify study data or content on the page, just the version stamp.SummaryDifference0.1%

- Check13 days agoChange DetectedA new revision v3.6.2 was added to the history, and the v3.6.0 entry was removed from the current history view, reflecting an updated record status.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision (v3.6.0) appears in the history, and the recruitment status is updated to indicate enrollment is closed, replacing the prior revision (v3.5.5).SummaryDifference0.2%

- Check34 days agoChange DetectedThe revision label on the page updated from v3.5.4 to v3.5.5, signaling a new version of the study record.SummaryDifference0.1%

- Check48 days agoChange DetectedNo textual additions or deletions are documented for this record.SummaryDifference0.1%

- Check55 days agoChange DetectedA new site revision entry Revision: v3.5.4 was added to the history, replacing the prior v3.5.3. This reflects a general site update rather than a modification to study content.SummaryDifference0.1%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.